C12N 15/8776
Primate embryos
Official title: {Primate embryos}
C12N15/8776 (Primate embryos) appears on 18 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 42
- Assignees
- 17
- Inventors
- 63
- Latest grant
- 17 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 4 |
| 2011 | 0 | 2 |
| 2012 | 0 | 5 |
| 2013 | 2 | 1 |
| 2014 | 1 | 3 |
| 2015 | 0 | 0 |
| 2016 | 5 | 4 |
| 2017 | 1 | 2 |
| 2018 | 1 | 4 |
| 2019 | 2 | 2 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Method for preparing non-human primate somatic cell cloned animal17 Sep 2024US 12,091,676 B2Center for Excellence In Brain Science and Intelligence Technology, Chinese Academy of Sciences
- Methods of enhancing chromosomal homologous recombination9 May 2023US 11,643,670 B2Massachusetts Institute of Technology
- Parthenogenic activation of human oocytes for the production of neuronal cells10 May 2022US 11,324,778 B2International Stem Cell Corporation
- Methods of enhancing female fertility23 Nov 2021US 11,179,423 B2Palo Alto Investors
- Methods for making and using modified oocytes16 Mar 2021US 10,947,562 B2New York Stem Cell Foundation, Inc.
- Parthenogenic activation of human oocytes for the production of human embryonic stem cells25 Aug 2022US 2022/0265728 A1International Stem Cell Corporation
- Methods for making and using modified oocytes1 Jul 2021US 2021/0198697 A1New York Stem Cell Foundation, Inc.
- Method for preparing non-human primate somatic cell cloned animal21 Jan 2021US 2021/0017543 A1Center for Excellence In Brain Science and Intelligence Technology, Chinese Academy of Sciences
- Methods and compositions to increase human somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation, and derivation of human nt-esc11 Jun 2020US 2020/0181648 A1
- Methods for making and using modified oocytes7 Nov 2019US 2019/0338313 A1New York Stem Cell Foundation, Inc.
Most cited
By later US patents
- Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells5US 7,732,202 B2International Stem Cell Corporation · 2010
- Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension3US 8,420,393 B2International Stem Cell Corporation · 2013
- Human embryonic stem cell line prepared by nuclear transfer of a human somatic cell into an enucleated human oocyte3US 8,647,872 B2H. Bion Co., Ltd. · 2014
- Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same1US 8,496,941 B2National Institute of Advanced Industrial Science and Technology · 2013